Direct interaction between macrophages and satellite cells (Dumont and Frenette, 2013; Ceafalan et al., 2017; Du et al., 2017; Wehling-Henricks et al., 2018) , and defects in skeletal muscle regeneration in the absence of macrophage participation (Arnold et al., 2007; Melton et al., 2016) , highlight the necessity of these cells for skeletal muscle repair. In vitro, M1 macrophages promote skeletal muscle cell proliferation and M2 macrophages promote differentiation, suggesting that macrophages may play a role in skeletal muscle growth adaptations, as well as repair (Arnold et al., 2007; Saclier et al., 2013b) .
Skeletal muscle is a highly adaptable tissue, able to respond to a wide range of external stimuli, such as exercise, inactivity, hormones and nutritional signals. In contrast to the clearly defined, strongly polarizing responses elicited by acute skeletal muscle injury, the role of tissue resident macrophages during less polarizing processes, such as responses to the aforementioned stimuli, is relatively unknown.
Under non-damaging exercise conditions, animal studies report an increase in macrophage populations following aerobic and resistance exercise, linked to both metabolic and growth adaptations (DiPasquale skeletal muscle macrophage abundance is affected by aging, obesity and diabetes (Przybyla et Reidy et al., 2017) ; however, the inconsistent use of macrophage markers across studies has made the interpretation of these findings difficult. Further, the applicability of the distinctive M1/M2 markers of polarized macrophages to tissue resident macrophages is unclear, as surface markers may not be mutually exclusive on resident macrophages under non-polarizing conditions (Italiani and Boraschi, 2014) . Thus, there is a need in the field for a standardized, validated method for identifying and quantifying macrophages in human skeletal muscle. Establishing a simple and reproducible protocol for studying muscle macrophages will aide in the characterization of their role in muscle adaptations to various stimuli, independent of injury.
Although results from studies of skeletal muscle macrophages in animal models are informative, these studies often use macrophage markers that are not directly translatable for use in humans. Even when human homologs do exist, the same surface markers in mouse and rat skeletal muscles often identify different populations in human skeletal muscles, complicating the extrapolation of findings from rodent models to human studies (Murray et al., 2014) . For example, CD68 is used as a pan-macrophage marker in humans and an M1 marker in mice. There is a need in the field for a standardized, validated method for identifying and quantifying macrophages in human skeletal muscle. Taking into account the limited mass of frozen muscle tissue available for analyses from human skeletal muscle biopsies (normally in the range of 100 mg), an immunohistochemical method is the most feasible approach to identifying and quantifying human skeletal muscle macrophage populations.
A variety of markers have been used to characterize human macrophages by flow cytometry. The most detailed studies have been performed utilizing peripheral blood mononuclear cells (PBMCs), artificially polarized to an M1 or M2 phenotype (Martinez et al., 2006; Ambarus et al., 2012; Iqbal, 2015) .
These in vitro studies characterize the expression of various marker combinations on M1 and M2 macrophages and provide a good starting point for choosing markers to identify macrophage populations in frozen human skeletal muscle tissue. CD14 has been identified as a monocyte marker, expressed mainly by macrophages but also neutrophils and dendritic cells (Table 1) . In blood, CD14 costaining with CD16 is used to stratify monocytes into three subsets: classical (CD14++/CD16-), intermediate (CD14++/CD16+) and non-classical (CD14+/CD16++) (Sprangers et al., 2016; Boyette et al., 2017) . It is thought that classical monocytes give rise to tissue macrophages under homeostatic conditions; however, during an inflammatory insult all monocyte populations differentiate into macrophages (Italiani and Boraschi, 2014; Sprangers et al., 2016) . In tissue, CD16 is predominantly used to identify NK cells, but is also expressed on neutrophils, granulocytes, dendritic cells and some macrophage populations (Table 1) . CD11b is a commonly used marker and is expressed on subsets of lymphocytes and monocytes, these include natural killer (NK) cells, granulocytes and macrophages (Table 1) . CD68 is expressed by cells in the monocyte lineage, including macrophages, and is the most commonly used macrophage marker in human skeletal muscle tissue ( antibodies against some of the markers described above (CD11b, CD14, CD16, CD86 and CD206) and performed multichannel flow cytometry. Due to the intracellular expression of CD68, we were not able to include CD68 in flow cytometry analyses. Mononuclear cells from skeletal muscle did not express CD16, but co-expressed the other 4 markers tested ( Figures 1A-1E ). Thus, human skeletal muscle macrophages have a 'mixed' phenotype, co-expressing both M1 (CD86) and M2 (CD206) cell surface markers ( Figure 1D ). macrophages (denoted in dark blue) also express the pan-monocyte markers CD11b and CD14.
Red boxes indicate cells that are double positive for the markers shown.
Using these 4 cell surface antibodies against CD11b, CD14, CD86 and CD206 that label skeletal muscle resident macrophages, we sought to develop a simple and reproducible immunohistochemical method for identification of macrophages in fresh frozen human skeletal muscle sections. CD68 is a commonly used pan-macrophage marker in human skeletal muscle. However, CD68 expression is predominantly intracellular, requiring permeabilization steps to perform immunohistochemistry (IHC). 5. After obtaining a single cell suspension, centrifuge at 500 x g (rcf) (relative centrifugal force or g-force) for 5 min at 4 °C with gentle braking to pellet cells.
6. Wash the cell pellet by resuspending with 1 ml sterile (autoclaved) 1x PBS, at this step, cell suspensions from multiple muscle chunks can be recombined back into one sample if desired.
Repeat
Step A5 to pellet cells and resuspend in 500 µl of fluorophore-conjugated antibody cocktail (Table 3 ).
8. Mix well by pipetting up and down 6-8 times and incubate at 4 °C in the dark for 1 h.
9. Centrifuge at 500 x g (rcf) for 5 min at 4 °C with gentle braking to pellet cells, then resuspend in sterile 1x PBS to wash.
Step A9 for a second wash then resuspend cell pellet in 1 ml sterile 1x PBS for FACS. b. An unstained sample of cell suspension should always be run to determine the location of negative cell populations (Liu et al., 2015 e. Isotype control antibodies in the appropriate fluorophores are used as a control to ensure antibody staining specificity (Table 3) .
12. FACS sort CD11b+/CD14+ cells for immunocytochemistry (ICC) and collect into 1x PBS.
13. Following the sort, pellet cells by centrifugation at 500 x g for 5 min at 4 °C and resuspend in 600 µl of 1x PBS.
14. Load 200 µl of cell suspension into a Shandon Single Cytofunnel and centrifuge with a Shandon Cytospin 4 at 1,000 revolutions per minute (RPM) for 3 min to place cells onto Shandon Single Cytoslides.
15. Use PAP pen to trace the circle printed on the slide indicating where the sample is located and allow slides to air dry on the bench at room temperature (RT) for 30 min.
16. Follow Steps C8-C22 of the CD11b/CD206 double IHC protocol below, replacing the primary antibody against CD11b with anti-CD68 (
Step C20c) at a 1:100 dilution ( Table 2 ). 19. Visualize CD68+ staining by adding alkaline phosphatase substrate using the ImmPACT Vector
Red kit according to the manufacturer's protocol (Table 2 ).
a. Staining intensity can be monitored using a standard light microscope to determine the optimal amount of staining time; 10-20 min was found to be sufficient.
b. Staining will be both chromogenic (appearing red) and fluorescent (visible using a TRITC filter cube).
Step A18 (above) to wash and coverslip using 50% 1x PBS/50% glycerol.
21. Image or store for up to a month at 4 °C in the dark (Figure 2 ).
www.bio-protocol.org/e2883 1. Mix tragacanth gum powder and O.C.T compound with a Teflon coated spatula at a ratio of 1 part tragacanth gum powder to 1.5 parts O.C.T to make a thick paste (mounting medium).
2. Apply mounting medium to cork and mold into a donut shape, leaving a hole in the center where the muscle specimen will be placed ( Figure 3A ). 7. Using fine-tipped forceps and the Teflon spatula, gently roll the skeletal muscle pieces together into a solid cylindrical shape (muscle cylinder).
8. Roll the muscle cylinder onto the tip of the spatula so that the bottom (the edge you trimmed) is aligned with the tip of the spatula.
9. Stand the muscle cylinder/spatula up so that skeletal muscle fibers are now running perpendicular to bench and the untrimmed, aligned edge (top) is facing up.
10. Gently place the muscle cylinder into the center of the mounting medium donut, against one side of the donut and use forceps to push the muscle cylinder off of the spatula. Remove the spatula. The muscle cylinder is now perpendicular to the surface of the cork with the bottom, trimmed end on the cork and the long axis of the skeletal muscle fibers sticking up ( Figure 3C ).
11. Using the spatula, work the mounting medium in to completely enclose the skeletal muscle specimen, closing gaps and leaving no air pockets between the muscle cylinder and the mounting medium (this protects the muscle specimen from freeze damage).
12. Sculpt the top of the mounting medium so that it is flush with the top of the skeletal muscle specimen.
13. Rapidly freeze the IHC mount by placing into liquid nitrogen cooled isopentane for 2 min.
www 2883 a. Isopentane should be a slushy consistency, with solid just beginning to form.
b. The cork side of the mount should be facing up and the skeletal muscle specimen facing down, completely submerged in the cooled isopentane.
14. Once frozen, use tongs to remove the IHC mount from the cooled isopentane and place on dry ice to rest for 5 min.
15. The final IHC mount is now ready to be stored at -80 °C until you are ready to section ( Figures   3D-3E ). 3. Allow the IHC mount to acclimate to the temperature of the chamber for 1 h prior to sectioning.
The chamber temperature may need to be adjusted for each sample in order to achieve flat sections with the greatest number of fibers in cross-section.
www.bio-protocol.org/e2883 b. Sample should be adjusted so the top of the mount is perpendicular to the blade when sectioning. In order to obtain cross-sectional fibers, small adjustments in the angle of the chuck/mount may need to be made. Once adjustments are made, quality sections should be cut containing at least 100 muscle fibers and no more than 20% longitudinal fibers.
5. Using the anti-roll plate to keep sections from curling, cut frozen sections at 7 µm and pick up onto charged Superfrost Plus slides.
6. Allow sections to dry on the benchtop at RT, then circle samples to be stained using an ImmEdge PAP pen.
7. Allow PAP pen to dry for an additional 20-30 min.
8. Fix sections at -20 °C for 3 min by submerging slides in a Coplin jar containing ice cold acetone.
Acetone should be stored at -20 °C to maintain temperature.
9. Quickly dab slide edges onto a paper towel to drain excess acetone and transfer to a Coplin jar filled with 1x PBS at RT.
10. Rock the slides in 1x PBS for 5 min; repeat wash step two more times for a total of three washes.
11. Remove slides from Coplin jar, gently flick to remove excess 1x PBS, wipe the back of the slide with a paper towel and place into a humidifying slide chamber containing approximately 1.5 cm of water in the reservoir.
12. Block endogenous peroxidases by pipetting 3% hydrogen peroxide onto the sections and allow to incubate, rocking at RT for 8 min.
13. Gently dump the hydrogen peroxide onto a paper towel to discard, replace with 1x PBS and rock for 5 min at RT.
Step C13 two more times for a total of three washes.
15. Dump excess 1x PBS onto a paper towel, flick slide, wipe the back with a paper towel and place back in the slide chamber. Repeat this wash with 1x PBS a total of three times.
18. Dump 1x PBS onto a paper towel, flick slide to remove excess 1x PBS, wipe the back of the slide with a paper towel and return to the slide chamber.
19. Add enough volume of 2.5% normal horse serum (NHS) to completely cover the sections and rock at 4 °C, overnight.
www.bio-protocol.org/e2883 a. To ensure the specificity of the primary antibody against CD11b, an isotype specific control should also be prepared by adding purified mouse IgG1, κ to a section at the same concentration as the primary antibody against CD11b (0.1 mg/ml). The isotype control listed in Table 2 has a concentration of 0.5 mg/ml and should be diluted 1:500 in 2.5% NHS and incubated overnight at 4 °C, rocking ( Figure 4A ).
b. To determine signal produced by background staining of the tissue specimen, a no primary antibody control should be included. Prepare the no primary antibody control by covering the section in 2.5% NHS alone (omitting any antibody) and incubating overnight at 4 °C, rocking ( Figure 4B ).
c. For identification of macrophages using CD68, substitute anti-CD68 primary antibody, diluted 1:100, for primary antibody against CD11b in this step (Table 2 ) (Figure 2A ).
d. For identification of specific M2 macrophage populations, substitute anti-CD163 primary antibody, diluted 1:50, for anti-CD11b primary antibody in this step and continue with the staining protocol as written (Table 2 ).
e. For identification of satellite cell populations, anti-Pax7 antibody, diluted 1:100, should be substituted for primary antibody against CD11b at this step (Table 2 ).
Remove primary antibody from sections and wash (as outlined in
Step C17 above) four times, 5 min with 1x PBS, rocking at RT.
22. Dump excess 1x PBS onto a paper towel, flick to remove remaining 1x PBS, wipe the back of the slide with a paper towel, return to the slide chamber.
23. Add the biotinylated goat anti-mouse IgG1, diluted 1:1,000 in 2.5% NHS, and incubate by rocking for 90 min at RT.
24. Remove the biotinylated antibody from the sections and repeat the wash in Steps C21 and C22.
25. Add the SA-HRP, diluted 1:500 in 1x PBS, and incubate for 60 min, rocking at RT.
26. Remove the SA-HRP from the sections and wash three times, 5 min with 1x PBS, rocking at RT.
After the third wash, repeat
Step C22 then add TSA 488, diluted 1:500 in 1x PBS, and incubate for 20 min, rocking at RT.
28. Remove the TSA 488 and repeat the washes in Step C26.
Repeat
Steps C15-C18 to block the streptavidin and biotin used to label CD11b and prevent false co-staining.
30. Add enough volume of 2.5% NHS to completely cover the sections and rock at RT for at least 60 min (sections can be left in 2.5% NHS longer if desired). To determine signal produced by background staining of the tissue specimen, a no primary antibody control should be included at this step also. Prepare the no primary antibody control by covering the section in 2.5% NHS alone (omitting any antibody) and incubating overnight at 4 °C, rocking ( Figure 4C ).
32. Remove CD206 antibody from sections and repeat Steps C21 and C22 to wash.
33. Add biotinylated rabbit anti-goat IgG, diluted 1:500 in 2.5% NHS, and incubate for 90 min at RT, rocking.
34. Remove the biotin from the sections and wash four times, 5 min with 1x PBS, rocking at RT.
35. Add the SA-594, diluted 1:200 in 1x PBS, and incubate for 60 min, rocking at RT.
36. Remove the SA-594 from the sections and wash three times, 5 min with 1x PBS, rocking at RT.
37. Incubate sections with DAPI, diluted 1:10,000 in 1x PBS, for 10 min at RT, rocking.
38. Remove DAPI from the sections and wash three times, 5 min with 1x PBS.
Dump excess 1x PBS onto a paper towel and add enough volume of PBS/Glycerol or
Vectashield mounting medium to cover the sections (20-50 µl/slide).
40. Gently lower coverslip onto the slide, avoiding the formation of bubbles under the coverslip.
Allow the mounting medium to spread by leaving the slides laying coverslip up for 5-10 min.
41. Drain excess mounting medium from slides by standing vertical on a paper towel for 5 min. 
Data analysis
Quantification of skeletal muscle fiber number and macrophage abundance 1. General guidelines for skeletal muscle macrophage analysis a. Sections to be analyzed for macrophage numbers should contain at least 50-100 skeletal muscle fibers.
b. Non-specific staining is common around the edges of skeletal muscle sections; therefore, exclude the edges when counting macrophages.
c. Do not include longitudinal skeletal muscle fibers in the area to be counted; this skews the number of macrophages/fiber.
d. Areas containing blood patches, edema or fibrosis will sometimes be observed in damaged tissues ( Figure 5B ). These areas are usually filled with macrophages and shouldn't be included in the same analysis as macrophages located in between skeletal muscle fibers ( Figure 5A ). Whether these macrophages should be quantified depends on the aim of the study.
www.bio-protocol.org/e2883 2. Adjust the image display in any channel so that the background staining is visible and individual skeletal muscle fibers can be distinguished (Figures 6A-6B ).
www.bio-protocol.org/e2883 4. Adjust the image display so that CD11b+ macrophages (green) and DAPI+ cell nuclei (blue) can be clearly observed and cell shape/morphology is distinct ( Figures 7A-7B ).
a. Isotype-specific staining controls for antibody specificity should be used to help determine the appropriate display adjustment for identifying true positive staining ( Figure 5A ).
b. No primary antibody staining controls for non-specific binding of antibodies/amplification reagents can be used to aid in determining background tissue staining and display adjustment for counting ( Figures 4B-4C ).
www.bio-protocol.org/e2883 Other areas were not counted due to a lack of DAPI staining (yellow arrows). Scale bars = 100 µm. 2. We have used this protocol to identify macrophage populations in subjects ranging from age 19
to 83 and spanning a wide range of activity levels. We have found the percentage of total CD11b+ macrophages that co-express CD206 (~82%) remains relatively consistent across demographics; however, the abundance (number/fiber) and phenotype may be affected by age, obesity and/or exercise.
3. We acknowledge that surface marker expression is not sufficient to infer function and further analyses should be employed to determine functional characteristics of macrophage populations.
4. Skeletal muscle macrophages display heterogeneous morphology; however, we do not currently include macrophage morphology as a variable in our analyses (Figure 8 ). Though morphology alone is likely not enough to distinguish macrophage populations, we believe macrophage morphology may be an important and telling variable for some studies and may provide further insight into macrophage phenotype beyond surface marker expression alone.
5. Post sectioning drying time depends on the size of the sample, but 3-4 h are usually sufficient for skeletal muscle biopsies. Following drying, slides can be stored at -20 °C if staining will be done at a later time.
6. If samples were stored at -20 °C, slides should be allowed to warm to RT for 15-20 min prior to acetone fixation.
7. Batch controls should be included if multiple sets of staining will be done at different time points within a single study and should include at least one control and one experimental sample.
8. For all reagents pipetted onto the slide, use enough volume to cover the sections and fill the area you created with the PAP pen, usually between 200 and 500 µl/slide.
9. During the incubation with 3% hydrogen peroxide, you may see bubbles form on the section indicating that the peroxide is working; a lack of bubbling will not affect the staining outcome but is indicative of poor tissue quality.
Following
Step C26, slides can be coverslipped with PBS/Glycerol and staining can be checked prior to moving forward with the protocol. Incubate slides in a Coplin jar with 1x PBS to remove the coverslips (they will fall off), wash 2 or 3 times with 1x PBS and continue with Step C27.
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b. Take care not to over-drain the slides; this will lead to the formation of air pockets underneath the coverslip.
c. For long-term storage, slides can be mounted with Vectashield mounting medium.
d. Slides can be sealed by painting the edges of the coverslip with nail polish to prevent the formation of air pockets underneath the coverslip over time.
12. Both CD11b and CD68 antibodies are a mouse IgG1 isotype and both require amplification using Superboost Tyramide signal amplification reagents. For these reasons, co-staining of CD11b and CD68 is not possible (false positive double staining occurred).
13. This protocol can be adapted to identify a subset of CD206+ macrophages expressing CD163
by substituting CD163 primary antibody (see Table 1 ) in place of CD11b primary antibody and following the remaining protocol as written.
14. Primary antibody for Pax7 (see Table 1 ) can be substituted for CD11b primary antibody to label satellite cells; the remaining protocol steps are the same (Figure 10 ).
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ii. Focus points are best set using the FITC channel (CD11b staining), to ensure that macrophages are in focus with clear morphology.
2. Staining must be located near DAPI (within 5 µm), but does not have to be directly on top of DAPI staining. If the morphology is a macrophage and it is close but not touching DAPI, we will count the event as a macrophage (Figure 7 ).
3. We have found that CD163+ macrophages make-up a subset of total CD206+ macrophages.
Thus, if quantifying these populations, CD206+ macrophages should be counted as the 'parent' macrophage population (similar to CD11b above).
4. Establishing a set of counting parameters prior to analyzing data sets is helpful when quantifying macrophages and also helps minimize variance between counters.
5. Choose a handful of images as a 'guide' counting set and use these images to set up guidelines for how macrophages will be identified and to train new counters.
a. It is important to stay consistent between images, groups and studies with regard to the identification of macrophages.
b. Within one data set it is better to have the same blinded counter to analyze the entire data set due to variation between counters.
c. We have found that although absolute numbers vary between counters, overall trends with regard to increases or decreases in the abundance of macrophage populations remain consistent if basic guidelines are outlined and followed. 
